Does cancer that occurs during or after anti–tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents
Pauline Raaschou, Julia F. Simard, Martin Neovius, Johan Askling, Anti-Rheumatic Therapy in Sweden Study GroupVolume:
63
Year:
2011
Language:
english
Pages:
11
DOI:
10.1002/art.30247
File:
PDF, 149 KB
english, 2011